Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• Huntington Ingalls wins $336 million Navy contract for CVN 82
• Dell Technologies (DELL) added to S&P 100 index